Rose Pharma-Sponsored Patient Preference Research Accepted for Presentation at ObesityWeek® 2026
PRESS RELEASE
Research examines patient preferences for…
MannKind and Rose Pharma Inc Enter Licensing and Collaboration Agreement to Develop an Inhaled Rapid-Acting, Short-Duration GLP-1 for Weight Management
PRESS RELEASE
Collaboration combines Rose Pharma investigational…
Presenting Phase 2a Results of ROSE-010 at Obesity Week 2025
PRESS RELEASE
Rose Pharma Inc. to Present Positive Phase 2a…
